218 related articles for article (PubMed ID: 28855137)
21. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
[TBL] [Abstract][Full Text] [Related]
22. Development of miconazole nitrate containing chitosan microcapsules and their anti-Aspergillus niger activity.
Yuen CW; Kan CW; Cheuk KL; Cheung HC; Cheng SY; Yip J; Lam PL
J Microencapsul; 2012; 29(5):505-10. PubMed ID: 22172026
[TBL] [Abstract][Full Text] [Related]
23. Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections.
Amaral AC; Saavedra PHV; Oliveira Souza AC; de Melo MT; Tedesco AC; Morais PC; Soares Felipe MS; Bocca AL
Colloids Surf B Biointerfaces; 2019 Feb; 174():409-415. PubMed ID: 30481701
[TBL] [Abstract][Full Text] [Related]
24. Microwave-assisted microemulsion technique for production of miconazole nitrate- and econazole nitrate-loaded solid lipid nanoparticles.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Eur J Pharm Biopharm; 2017 Aug; 117():141-150. PubMed ID: 28411057
[TBL] [Abstract][Full Text] [Related]
25. Dendrimer-mediated permeation enhancement of chlorhexidine digluconate: Determination of in vitro skin permeability and visualisation of dermal distribution.
Kirkby M; Sabri AB; Scurr DJ; Moss GP
Eur J Pharm Biopharm; 2021 Feb; 159():77-87. PubMed ID: 33359754
[TBL] [Abstract][Full Text] [Related]
26. Development and evaluation of ultra-small nanostructured lipid carriers: novel topical delivery system for athlete's foot.
Singh S; Singh M; Tripathi CB; Arya M; Saraf SA
Drug Deliv Transl Res; 2016 Feb; 6(1):38-47. PubMed ID: 26542152
[TBL] [Abstract][Full Text] [Related]
27. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity.
Mendes AI; Silva AC; Catita JA; Cerqueira F; Gabriel C; Lopes CM
Colloids Surf B Biointerfaces; 2013 Nov; 111():755-63. PubMed ID: 23954816
[TBL] [Abstract][Full Text] [Related]
28. Impact of Process Parameters on Particle Size Involved in Media Milling Technique Used for Preparing Clotrimazole Nanocrystals for the Management of Cutaneous Candidiasis.
Patel V; Sharma OP; Mehta TA
AAPS PharmSciTech; 2019 Apr; 20(5):175. PubMed ID: 31028492
[TBL] [Abstract][Full Text] [Related]
29. Propylene glycol liposomes as a topical delivery system for miconazole nitrate: comparison with conventional liposomes.
Elmoslemany RM; Abdallah OY; El-Khordagui LK; Khalafallah NM
AAPS PharmSciTech; 2012 Jun; 13(2):723-31. PubMed ID: 22566173
[TBL] [Abstract][Full Text] [Related]
30. Improved Dermal and Transdermal Delivery of Curcumin with SmartFilms and Nanocrystals.
Eckert RW; Wiemann S; Keck CM
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804137
[TBL] [Abstract][Full Text] [Related]
31. Nile red nanosuspensions as investigative model to study the follicular targeting of drug nanocrystals.
Corrias F; Schlich M; Sinico C; Pireddu R; Valenti D; Fadda AM; Marceddu S; Lai F
Int J Pharm; 2017 May; 524(1-2):1-8. PubMed ID: 28336458
[TBL] [Abstract][Full Text] [Related]
32. Composite Microparticles Based on Natural Mucoadhesive Polymers with Promising Structural Properties to Protect and Improve the Antifungal Activity of Miconazole Nitrate.
Tejada G; Lamas MC; Sortino M; Alvarez VA; Leonardi D
AAPS PharmSciTech; 2018 Nov; 19(8):3712-3722. PubMed ID: 30238304
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
Lamfon H; Porter SR; McCullough M; Pratten J
J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
[TBL] [Abstract][Full Text] [Related]
34. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
Ghosh I; Schenck D; Bose S; Ruegger C
Eur J Pharm Sci; 2012 Nov; 47(4):718-28. PubMed ID: 22940548
[TBL] [Abstract][Full Text] [Related]
35. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
[TBL] [Abstract][Full Text] [Related]
36. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(epsilon-caprolactone) nanocapsule encapsulated form and as a digluconate.
Lboutounne H; Chaulet JF; Ploton C; Falson F; Pirot F
J Control Release; 2002 Aug; 82(2-3):319-34. PubMed ID: 12175746
[TBL] [Abstract][Full Text] [Related]
37. Enhancing Topical Delivery of Resveratrol through a Nanosizing Approach.
Sinico C; Pireddu R; Pini E; Valenti D; Caddeo C; Fadda AM; Lai F
Planta Med; 2017 Mar; 83(5):476-481. PubMed ID: 27220078
[TBL] [Abstract][Full Text] [Related]
38. Synergistic inhibition of the growth in vitro of Microsporum canis by miconazole and chlorhexidine.
Perrins N; Bond R
Vet Dermatol; 2003 Apr; 14(2):99-102. PubMed ID: 12662267
[TBL] [Abstract][Full Text] [Related]
39. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent.
Jain S; Jain S; Khare P; Gulbake A; Bansal D; Jain SK
Drug Deliv; 2010 Aug; 17(6):443-51. PubMed ID: 20486871
[TBL] [Abstract][Full Text] [Related]
40. In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum.
Pershing LK; Corlett J; Jorgensen C
Antimicrob Agents Chemother; 1994 Jan; 38(1):90-5. PubMed ID: 8141586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]